Prevalence of Multidrug‐Resistant Organisms in Patients Undergoing Free Flap Reconstruction

Male Methicillin-Resistant Staphylococcus aureus Antibiotic Prophylaxis Kansas Middle Aged Plastic Surgery Procedures Staphylococcal Infections Free Tissue Flaps 3. Good health 03 medical and health sciences 0302 clinical medicine Head and Neck Neoplasms Drug Resistance, Multiple, Bacterial Humans Surgical Wound Infection Female Retrospective Studies
DOI: 10.1002/lary.29268 Publication Date: 2020-11-12T13:28:06Z
ABSTRACT
Objectives/HypothesisThe purpose of this study is to evaluate the relationship between antibiotic prophylaxis and prevalence of multidrug‐resistant organisms (MDRO) in patients undergoing head and neck cancer reconstruction.Study DesignRetrospective Chart Review.MethodsRetrospective review of patients who underwent head and neck free flap reconstruction at our institution between 2009 to 2016.ResultsOf the 145 patients that underwent head and neck tumor removal surgery using free tissue flaps to cover the defect and therafter received antibiotic prophylaxis, 30 (20.7%) developed postoperative surgical site (n = 17, 55.7%) or distant (n = 13, 43.4%) infections. Seven had a multidrug‐resistant infection, the most common with Methicillin‐Resistant Staphylococcus aureus (MRSA). There was no significant relationship between antibiotic spectrum or duration to the development of postoperative infections or MDRO. Pseudomonas and MRSA infections were low overall with only one multidrug‐resistant Pseudomonas infection.ConclusionsThe choice of antibiotic prophylaxis should cover organisms these patients are at highest risk for including anaerobes and Gram‐negative organisms. A shorter duration of antibiotic prophylaxis should be considered given no increased risk of postoperative infection nor MDRO. Finally, one must be aware of the potential threat of multidrug‐resistant Pseudomonas and MRSA amongst this vulnerable population and identity these with culture driven treatment.Level of Evidence4 Laryngoscope, 131:E1881–E1887, 2021
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (29)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....